Covid-19 pandemic: Abbott to supply over 1 million antibody tests to India
US-based healthcare technology maker Abbott on Monday said it can supply over one million of its laboratory-based serology blood test for the detection of the antibody, IgG (Immunoglobulin G), that identifies if a person has had the novel coronavirus (Covid-19). Abbott said it is already in the process of delivering antibody tests to leading government and private hospitals and labs in Maharashtra, Delhi, West Bengal, Uttar Pradesh, Jammu and Kashmir and Gujarat. "Abbott is pleased to contribute to ICMR's (Indian Council of Medical Research) Covid-19 antibody testing strategy to use IgG CLIA antibody tests," Narendra Varde, General Manager and Country Head at Abbott's diagnostics business in India, said in a statement. Read More